JP3961064B2 - 腎疾患予防及び／又は治療剤 - Google Patents

腎疾患予防及び／又は治療剤 Download PDF

Info

Publication number
JP3961064B2
JP3961064B2 JP09498997A JP9498997A JP3961064B2 JP 3961064 B2 JP3961064 B2 JP 3961064B2 JP 09498997 A JP09498997 A JP 09498997A JP 9498997 A JP9498997 A JP 9498997A JP 3961064 B2 JP3961064 B2 JP 3961064B2
Authority
JP
Japan
Prior art keywords
tcf
ala
lys
mutant
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP09498997A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10273446A (ja
JPH10273446A5 (enExample
Inventor
雅彦 木野崎
浩美 小川
博明 升永
文枝 小林
京二 山口
侃二 東尾
Original Assignee
第一製薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP09498997A priority Critical patent/JP3961064B2/ja
Application filed by 第一製薬株式会社 filed Critical 第一製薬株式会社
Priority to CA002253929A priority patent/CA2253929A1/en
Priority to PCT/JP1998/001221 priority patent/WO1998043665A1/ja
Priority to AU64208/98A priority patent/AU734794B2/en
Priority to US09/194,326 priority patent/US6306827B1/en
Priority to EP98909799A priority patent/EP0925791A4/en
Priority to ZA982606A priority patent/ZA982606B/xx
Publication of JPH10273446A publication Critical patent/JPH10273446A/ja
Publication of JPH10273446A5 publication Critical patent/JPH10273446A5/ja
Application granted granted Critical
Publication of JP3961064B2 publication Critical patent/JP3961064B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP09498997A 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤 Expired - Fee Related JP3961064B2 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP09498997A JP3961064B2 (ja) 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤
PCT/JP1998/001221 WO1998043665A1 (fr) 1997-03-28 1998-03-20 Agent preventif et/ou therapeutique pour les maladies des reins
AU64208/98A AU734794B2 (en) 1997-03-28 1998-03-20 Agent for preventing and/or treating renal disease
US09/194,326 US6306827B1 (en) 1997-03-28 1998-03-20 Method for preventing and/or treating renal disease
CA002253929A CA2253929A1 (en) 1997-03-28 1998-03-20 Preventive and/or therapeutic agent for kidney diseases
EP98909799A EP0925791A4 (en) 1997-03-28 1998-03-20 PREVENTIVE AND / OR THERAPEUTICALLY ACTIVE SUBSTANCE FOR KIDNEY DISEASES
ZA982606A ZA982606B (en) 1997-03-28 1998-03-27 Agent for preventing and/or treating renal disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP09498997A JP3961064B2 (ja) 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤

Publications (3)

Publication Number Publication Date
JPH10273446A JPH10273446A (ja) 1998-10-13
JPH10273446A5 JPH10273446A5 (enExample) 2005-01-20
JP3961064B2 true JP3961064B2 (ja) 2007-08-15

Family

ID=14125298

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09498997A Expired - Fee Related JP3961064B2 (ja) 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤

Country Status (7)

Country Link
US (1) US6306827B1 (enExample)
EP (1) EP0925791A4 (enExample)
JP (1) JP3961064B2 (enExample)
AU (1) AU734794B2 (enExample)
CA (1) CA2253929A1 (enExample)
WO (1) WO1998043665A1 (enExample)
ZA (1) ZA982606B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531673T2 (de) * 1994-12-27 2004-07-08 Daiichi Pharmaceutical Co., Ltd. Tcf mutante
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ES2274567T3 (es) 1997-03-14 2007-05-16 Daiichi Pharmaceutical Co., Ltd. Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
JP4252591B2 (ja) * 2006-08-08 2009-04-08 クロリンエンジニアズ株式会社 オゾン製造装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468400A (en) 1987-09-09 1989-03-14 Sapporo Breweries Human tumor cytotoxic factor htcf, production thereof and antitumor agent comprising said factor as active ingredient
JP3380573B2 (ja) * 1992-07-16 2003-02-24 第一製薬株式会社 Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
CA2100720C (en) * 1992-07-16 2003-03-11 Hiroaki Masunaga Medicinal composition comprising tcf-ii
DE69531673T2 (de) 1994-12-27 2004-07-08 Daiichi Pharmaceutical Co., Ltd. Tcf mutante

Also Published As

Publication number Publication date
US6306827B1 (en) 2001-10-23
JPH10273446A (ja) 1998-10-13
AU734794B2 (en) 2001-06-21
EP0925791A4 (en) 2004-06-16
ZA982606B (en) 1998-09-30
WO1998043665A1 (fr) 1998-10-08
AU6420898A (en) 1998-10-22
EP0925791A1 (en) 1999-06-30
CA2253929A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
US20190248864A1 (en) Polynucleotides encoding low density lipoprotein receptor
US20190192653A1 (en) Compositions and methods for tolerizing cellular systems
US20170348415A1 (en) Tolerogenic compositions and methods
US7705140B2 (en) DNAs encoding TNF receptor family members
EP3307305A1 (en) Targeted adaptive vaccines
AU2012358384A1 (en) Methods of increasing the viability or longevity of an organ or organ explant
CA2181431A1 (en) Haemopoietic maturation factor
JP2010509181A (ja) 融合ポリペプチドを細胞へ輸送する方法
US6338949B1 (en) Nucleic acids encoding receptor recognition factor stat4 and methods of use thereof
EP1809660B1 (en) A thymus-specific protein
JP3961064B2 (ja) 腎疾患予防及び／又は治療剤
JPH10500850A (ja) インターロイキン−６ スプライス変異体
JP2002501032A (ja) 急性間欠性ポルフィリン症（ａｉｐ）及び他のポルフィリン症の治療方法
JP4422330B2 (ja) 新規な免疫異常性疾患予防・治療用剤
KR100552434B1 (ko) 신질환 예방 및/또는 치료제_
EA009389B1 (ru) Использование растворимого cd164 при воспалительных и/или аутоиммунных нарушениях
US6605442B1 (en) Methods of testing drugs or agents that modulate the activity of receptor recognition factors
CN120285149A (zh) Pou2f2蛋白或其突变体在预防和治疗感染中的用途
CN100556455C (zh) 一种用于预防和治疗i型糖尿病的药物复合物及其应用
JP2553425B2 (ja) トロンビン結合性物質及びその製造法
WO1998056819A1 (en) Methods of regulating t cell and macrophage cytokine production, function and pathogenicity
CN117899223A (zh) 以nup35基因和或以nup35蛋白作为作用靶点的物质的应用及组合物
JPH08198899A (ja) 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物
WO2001038372A1 (en) A novel polypeptide-human paneth cell enhanced expression-like protein and the polynucleotide encoding said polypeptide
JPH08301898A (ja) 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070412

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070510

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070516

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100525

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100525

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100525

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100525

Year of fee payment: 3

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100525

Year of fee payment: 3

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100525

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100525

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees